Pharmarack Technologies Private Limited has been acquired by DigiHealth Technologies LLP, a platform set up by leading pharmaceutical companies in India
Pharmarack, co-founded by Pradyumn Singh, Kushal Bhandari and Amit Backliwal, is a portfolio company of IvyCap Ventures and other venture capitals. Headquartered in Pune, India, it is India’s largest tech-enabled and fully integrated business-to-business healthcare platform offering Software as a Service, fulfillment, digital payment and working capital financing solutions to key players in the Indian pharmaceutical industry, which includes pharmaceutical manufacturers, stockists, distributors and retailers. The company’s solutions enable pharmaceutical manufacturers, distributors and retailers to monitor the movement of goods and manage inventory on a real-time basis. This allows them to optimize inventory costs and minimize unfulfilled demand. With its services, Pharmarack captures and analyzes critical data, which is used to conduct analytics and market insights for its customers. All major pharmaceutical companies and large distributors in India use Pharmarack. For more information, please visit www.pharmarack.com.
The Pharmarack acquisition will help the consortium to develop a world-class pharmaceutical supply chain and distribution information technology ecosystem and support the government’s national digital health mission.
Gaurav Marathe, Managing Director at Lincoln, commented, “We are extremely pleased to have advised the shareholders and founders of Pharmarack on this transaction. With the new partners, the founders and management team are able to pursue their expansion plans and become India’s first tech-enabled, fully integrated solution provider to all stakeholders of the pharmaceutical industry.”
Lincoln acted as the exclusive financial advisor for Pharmarack, working closely with its shareholders and management throughout the sale process. This included providing advisory expertise and managing the transaction’s preparatory, marketing, negotiation and due diligence phases. The terms of the transaction are confidential.
Lincoln’s team worked very closely with us and played a pivotal role throughout the transaction negotiation and closing process while managing the complex situations seamlessly and addressing issues on a real-time basis.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised HealthEdge Investment Partners on the sale of Corridor to WellSky, a portfolio company of Leonard Green and TPG Capital
Lincoln International advised Align Capital Partners on the sale of VetEvolve to Varsity Healthcare Partners
Lincoln International advised Havencrest Capital Management on its majority investment in Tekton Research
Lincoln International advised Your Way Medicare on its sale to Accretive, a portfolio company of GTCR
Lincoln International advised Seventure and minority shareholders on the sale of TargEDys to Biocodex
Lincoln International advised KPS Capital Partners on its sale of LRE Medical to Gyrus Capital
Lincoln International advised IVC Evidensia, a portfolio company of EQT Partners, on its sale of a group of veterinary practices to Perwyn
Lincoln International advised The Anderson Group on its sale of Parkview Health Services to Flexpoint Ford
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.